Association of systemic comorbidity in diabetic serous macular detachment and comparison of various combination therapies in its management

Association of systemic comorbidity in diabetic serous macular detachment and comparison of various combination therapies in its management

Manoj Soman,1 Sunil Ganekal,2 Unnikrishnan Nair,1 KGR Nair11Chaithanya Eye Hospital and Research Institute, Trivandrum, Kerala, 2Nayana Superspecialty Eye Hospital and Research Center, Davangere, Karnataka, IndiaBackground: The purpose of this research was to study the association between systemic c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Soman M, Ganekal S, Nair U, Nair KGR
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2013
Materias:
Ophthalmology
RE1-994
Acceso en línea:https://doaj.org/article/09c32f6acbc641ed897e286928fef8c3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:09c32f6acbc641ed897e286928fef8c3
record_format dspace
spelling oai:doaj.org-article:09c32f6acbc641ed897e286928fef8c32021-12-02T06:37:50ZAssociation of systemic comorbidity in diabetic serous macular detachment and comparison of various combination therapies in its management1177-54671177-5483https://doaj.org/article/09c32f6acbc641ed897e286928fef8c32013-01-01T00:00:00Zhttp://www.dovepress.com/association-of-systemic-comorbidity-in-diabetic-serous-macular-detachm-a11950https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Manoj Soman,1 Sunil Ganekal,2 Unnikrishnan Nair,1 KGR Nair11Chaithanya Eye Hospital and Research Institute, Trivandrum, Kerala, 2Nayana Superspecialty Eye Hospital and Research Center, Davangere, Karnataka, IndiaBackground: The purpose of this research was to study the association between systemic comorbidity in diabetic serous macular detachment (DSMD) and the effect of different forms of combination therapies in its management.Methods: In this prospective analysis, 34 eyes from 34 patients with DSMD were investigated for the presence of systemic comorbidity including anemia, dyslipidemia, nephropathy, and cardiac disease, and treated with combination therapy of either intravitreal bevacizumab + laser (group 1, n = 14) or intravitreal triamcinolone + laser (group 2, n = 20). Sequential macular laser was done 2 weeks after intravitreal pharmacotherapy in both groups. Outcome measures included visual acuity and central foveal thickness at 1 and 3 months.Results: The mean age of the patients was 55.6 ± 7.6 years. The commonest systemic association was nephropathy (82.3%). In group 1, mean visual acuity improved marginally from 6/17 at baseline to 6/16 at 1 month (P = 0.0001) and was maintained at 3 months (P = 0.008); and mean central foveal thickness decreased from 488.7 µm to 318.7 µm at 1 month (P = 0.0001) but increased to 414.4 µm at 3 months (P = 0.049). In group 2, mean visual acuity improved from 6/22 at baseline to 6/19 at 1 month (P = 0.0001) and 6/12 at 3 months (P = 0.0001); and mean central foveal thickness decreased from 428.8 µm to 323.8 µm at 1 month (P = 0.0001) to 269.2 µm at 3 months (P = 0.0001).Conclusion: Nephropathy should be ruled out in patients with DSMD. Although at 1 month both intravitreal triamcinolone and bevacizumab improved vision and decreased central foveal thickness in eyes with DSMD when administered along with focal laser treatment, the former had a more long-lasting effect in maintaining this gain at 3 months.Keywords: diabetic serous macular detachment, nephropathy, combination therapySoman MGanekal SNair UNair KGRDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2013, Iss default, Pp 113-119 (2013)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Soman M
Ganekal S
Nair U
Nair KGR
Association of systemic comorbidity in diabetic serous macular detachment and comparison of various combination therapies in its management
description Manoj Soman,1 Sunil Ganekal,2 Unnikrishnan Nair,1 KGR Nair11Chaithanya Eye Hospital and Research Institute, Trivandrum, Kerala, 2Nayana Superspecialty Eye Hospital and Research Center, Davangere, Karnataka, IndiaBackground: The purpose of this research was to study the association between systemic comorbidity in diabetic serous macular detachment (DSMD) and the effect of different forms of combination therapies in its management.Methods: In this prospective analysis, 34 eyes from 34 patients with DSMD were investigated for the presence of systemic comorbidity including anemia, dyslipidemia, nephropathy, and cardiac disease, and treated with combination therapy of either intravitreal bevacizumab + laser (group 1, n = 14) or intravitreal triamcinolone + laser (group 2, n = 20). Sequential macular laser was done 2 weeks after intravitreal pharmacotherapy in both groups. Outcome measures included visual acuity and central foveal thickness at 1 and 3 months.Results: The mean age of the patients was 55.6 ± 7.6 years. The commonest systemic association was nephropathy (82.3%). In group 1, mean visual acuity improved marginally from 6/17 at baseline to 6/16 at 1 month (P = 0.0001) and was maintained at 3 months (P = 0.008); and mean central foveal thickness decreased from 488.7 µm to 318.7 µm at 1 month (P = 0.0001) but increased to 414.4 µm at 3 months (P = 0.049). In group 2, mean visual acuity improved from 6/22 at baseline to 6/19 at 1 month (P = 0.0001) and 6/12 at 3 months (P = 0.0001); and mean central foveal thickness decreased from 428.8 µm to 323.8 µm at 1 month (P = 0.0001) to 269.2 µm at 3 months (P = 0.0001).Conclusion: Nephropathy should be ruled out in patients with DSMD. Although at 1 month both intravitreal triamcinolone and bevacizumab improved vision and decreased central foveal thickness in eyes with DSMD when administered along with focal laser treatment, the former had a more long-lasting effect in maintaining this gain at 3 months.Keywords: diabetic serous macular detachment, nephropathy, combination therapy
format article
author Soman M
Ganekal S
Nair U
Nair KGR
author_facet Soman M
Ganekal S
Nair U
Nair KGR
author_sort Soman M
title Association of systemic comorbidity in diabetic serous macular detachment and comparison of various combination therapies in its management
title_short Association of systemic comorbidity in diabetic serous macular detachment and comparison of various combination therapies in its management
title_full Association of systemic comorbidity in diabetic serous macular detachment and comparison of various combination therapies in its management
title_fullStr Association of systemic comorbidity in diabetic serous macular detachment and comparison of various combination therapies in its management
title_full_unstemmed Association of systemic comorbidity in diabetic serous macular detachment and comparison of various combination therapies in its management
title_sort association of systemic comorbidity in diabetic serous macular detachment and comparison of various combination therapies in its management
publisher Dove Medical Press
publishDate 2013
url https://doaj.org/article/09c32f6acbc641ed897e286928fef8c3
work_keys_str_mv AT somanm associationofsystemiccomorbidityindiabeticserousmaculardetachmentandcomparisonofvariouscombinationtherapiesinitsmanagement
AT ganekals associationofsystemiccomorbidityindiabeticserousmaculardetachmentandcomparisonofvariouscombinationtherapiesinitsmanagement
AT nairu associationofsystemiccomorbidityindiabeticserousmaculardetachmentandcomparisonofvariouscombinationtherapiesinitsmanagement
AT nairkgr associationofsystemiccomorbidityindiabeticserousmaculardetachmentandcomparisonofvariouscombinationtherapiesinitsmanagement
_version_ 1718399794511085568

Ejemplares similares